Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes

Drug Metabolism and Disposition

Volumn 26, Issue 4, 1998, Pages 299-305

  Draper, Alison J ^b   Madan, Ajay ^b   Smith, Kevin ^b   Parkinson, Andrew ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TESTOSTERONE; TESTOSTERONE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG OXIDATION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID SCINTILLATION COUNTING; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL; TESTOSTERONE METABOLISM;

ARYL HYDROCARBON HYDROXYLASES; CHROMATOGRAPHY, LIQUID; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; TESTOSTERONE; TRITIUM;

TRITIUM;

EID: 0031917613     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bjorkhem I (1972) On the rate limiting step in microsomal hydroxylation of steroids. Eur J Biochem 27:354-363.
2. Combalbert J, Fabre I, Dalet I, Derancourt J, Cano J and Maurel P (1989) Metabolism of cyclosporin A: Purification and identification of the rifampin-inducible human liver cytocfarome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos 17:197-207.
3. Gonzalez FJ (1990) Molecular genetics of the P450 superfamily. Pharmacol Ther 45:1-38.
4. Guengerich FP (1992) Human cytochrome P-450 enzymes. Life Sci 50:1471-1478.
5. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T and Waxman DJ (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051-5060.
6. Jurima-Romet M, Crawford K, Cyr T and Inaba T (1994) Terfenadine metabolism in human liver: in vitro inhibition by macrolide antibiotics and azoic antifungals. Drug Metab Dispos 22:849-857.
7. 6-testosterone from testosterone. Drug Metab Dispos 18:974-979.
8. Kronbach T, Fischer V and Meyer UA (1988) Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 43:630-635.
9. Kronbach T, Mathys D, Umeno M, Gonzalez FJ and Meyer UA (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 36:89-96.
10. Ling K-HL, Leeson GA, Burmaster SD, Hook RH, Rath MK and Cheng LK (1995) Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes. Drug Metab Dispos 23:631-636.
11. Parkinson A (1996) Biotransformation of Xenobiotics, in Casarett and Doull's Toxicology: The Basic Science of Poisons (Klaassen CD ed) 5th Ed., pp113-186, McGraw Hill, New York.
12. Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C and Parkinson A (1996) Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys 331:145-169.
13. Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Eddy AC, Aoyama T, VGelboin H, Gonzalez FJ and Trager WF (1992) Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol 5:54-59.
14. Rodrigues AD, Mulford DJ, Lee RD, Surber BW, Kukulka MJ, Ferrero JL, Thomas SB, Shet MS and Estabrook RW (1995) In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase: Comparison to human liver microsomes and precision-cut liver tissue slices. Drug Metab Dispos 23:765-775.
15. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
16. Sonderfan AJ and Parkinson A (1988) Inhibition of steroid 5α-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys 265:208-218.
17. Sonderfan AJ, Arlotto MP, Dutton DR, McMillen SK and Parkinson A (1987) Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys 255:27-41.
18. Tomaszewski JE, Jerina DM, Levin W and Conney AH (1976) A highly sensitive radiometric assay for zoxazolamine hydroxylation by liver microsomal cytochrome P-450 and P-448: Properties of the membrane-bound and purified reconstituted system. Arch Biochem Biophys 176:788-798.
19. Waxman DJ, Attisano C, Guengerich FP and Lapenson DP (1988) Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P450 enzyme. Arch Biochem Biophys 263:424-436.
20. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ and Korzekwa K (1991) Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 290:160-166.
21. 19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. J Biol Chem 258:8839-8847
22. Wrighton SA and Stevens JC (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22:1-21.
23. Wrighton SA, Brian WR, Sari M-A, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT and VandenBranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213.
24. Yun C-H, Okerholm RA and Guengerich FP (1993) Oxidation of the antihistaminic drug terfenadine in human liver microsomes: Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 21:403-409.